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Abstract
Background: Pancreatic Stone Protein (PSP) is a protein naturally produced mainly in the pancreas and the gut.
There is evidence from experimental and clinical trials that blood PSP levels rise in the presence of inflammation or
infection. However, it is not known whether PSP is superior to other established blood tests (e.g. White Blood
Count, Neutrophils or C - reactive protein) in predicting appendicitis in patients presenting with abdominal pain
and a clinical suspicion of appendicitis at the emergency room.
Methods/design: The PSP Appendix Trial is a prospective, multi-center, cohort study to assess the value of PSP in
the diagnostic workup of acute appendicitis. 245 patients will be prospectively recruited. Interim analysis will be
performed once 123 patients are recruited. The primary endpoint of the study concerns the diagnostic accuracy of
PSP in predicting acute appendicitis and therefore the evidence of appendicitis on the histopathological specimen
after appendectomy.
Discussion: The PSP Appendix Trial is a prospective, multi-center, cohort study to assess the value of PSP in the
diagnostic workup of acute appendicitis.
Trial registration: ClinicalTrials.gov: NCT01610193; Institution Ethical Board Approval ID: KEKZH- Nr. 2011–0501
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Background
Appendicitis is defined as an inflammation of the vermi-
form appendix and is a common condition and an ur-
gent surgical illness. It is one of the most common
causes of acute abdominal pain and remains a diagnostic
challenge. It has variable manifestations and generous
overlap with other clinical syndromes. In fact morbidity
increases significantly with the diagnostic delay and
left untreated, appendicitis has the potential for severe
complications, including perforation or sepsis, and may
even cause death. Despite diagnostic and therapeutic
advancement in medicine, appendicitis still remains a
clinical emergency [1].
No single sign, symptom, or diagnostic test exists
which accurately confirms an appendiceal inflammation.
The classic history of anorexia and periumbilical pain
followed by nausea, right lower quadrant (RLQ) pain,
and vomiting occurs in only 50% of cases [1,2].
Accepted etiologic factors of appendicitis are appendi-
ceal lumen obstruction and infection. The main thera-
peutic option still remains the surgical removal of the
vermiform appendix even though a few studies promote
an antibiotic treatment [3]. After admission to the emer-
gency department (ED), patients presenting with abdom-
inal pain caused by a variety of different etiologic factors
have to be worked up with the goal of approaching
* Correspondence: christoph.tschuor@usz.ch
†Equal contributors
Department of Surgery, University Hospital Zurich, Raemistrasse 100, Zurich
CH-8091, Switzerland
© 2012 Tschuor et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Tschuor et al. BMC Gastroenterology 2012, 12:154
http://www.biomedcentral.com/1471-230X/12/154
100% sensitivity for the diagnosis in a time-, cost-, and
consultation-efficient manner [4].
It is reported that appendectomy carries a complica-
tion rate of up to 15%, as well as increased associated
costs and the discomfort of hospitalisation and surgery
[5]. Delay in diagnosis and treatment account for much
of the associated mortality and morbidity. Therefore, the
goal of the surgeon is to diagnose appendicitis as early
as possible.
The overall mortality rate of 0.2 - 0.8% is attributable
to complications of the disease rather than to surgical
interventions [2]. The mortality rate in children ranges
from 0.1% to 1%; in patients older than 70 years, the rate
rises above 20%, primarily because of diagnostic and
therapeutic delay [4,6].
Appendiceal perforation is associated with increased
morbidity and mortality compared with non-perforating
appendicitis. The mortality risk of acute but not gan-
grenous appendicitis is less than 0.1%, but the risk rises
to 0.6% in gangrenous appendicitis. The rate of perfor-
ation varies from 16% to 40%, with a higher frequency
occurring in patients below 50 years (40-57%) and in
patients older than 50 years (55-70%), in whom misdiag-
nosis and delayed diagnosis are common. Complications
occur in 1-5% of patients with appendicitis. Postopera-
tive wound infections account for almost one third of
the associated morbidity [1,6,7].
PSP is a secretory protein produced predominantly in
the pancreas and the gut. There is evidence from experi-
mental and clinical trials that the levels of PSP in the
blood increase in the presence of inflammation or infec-
tion [8,9]. However, it is still unknown whether PSP is
superior to other established blood tests (e.g. WBC or
CRP) in predicting appendicitis in patients presenting
with abdominal pain and a clinical suspicion of appendi-
citis at the emergency room.
The objective of this trial is to 1) determine the diag-
nostic accuracy of PSP in predicting acute appendicitis
and 2) compare PSP with other established markers used
in the diagnostic work-up.
Methods/design
The PSP Appendix Trial is a prospective, multi-center,
cohort study to assess the value of PSP in the diagnostic
workup of acute appendicitis. Two hundred and forty
five patients will be recruited. Interim analysis will be
performed once 123 patients are recruited [Additional
file 1]. A power analysis will be performed on the actual
and precise data collected. At interim analysis the poten-
tial need to modify the sample size will be investigated.
If any changes are suggested by the external data moni-
toring committee, the principal investigators will decide
on the feasibility of the potential changes and submit a
formal addendum to the ethics committee. No changes
will be made to the protocol or study design unless first
approved by the ethics committee. Any changes to the
protocol approved by the ethics committee will be
updated at clinicaltrials.gov [NCT01610193].
Study objectives
The primary endpoint of the study is histopathological
diagnosis of appendicitis on the specimen after append-
ectomy in order to assess the diagnostic accuracy of PSP
calculated in predicting acute appendicitis. Secondary
endpoints concern:
1. Grade of appendicitis detected intraoperatively:
G0: Appendix without any abnormalities detected
introperatively
G1: Acute appendicitis
G2: Gangrenous appendicitis
G3: Perforated or phlegmon
G4: Periappendicular abscess
2. Alvarado Score elements which are obtained from
the patient’s history, the physical examination and
from laboratory tests. A score below 5 is strongly
against a diagnosis of appendicitis, while a score of 7
or more is strongly predictive of acute appendicitis.
In patients with an equivocal score of 5 or 6, a CT
scan is used to further reduce the rate of negative
appendectomy [10].
3. Pancreatic Stone Protein (PSP) blood serum/
plasma levels will be correlated with this score.
Surgical complications defined according to the
Clavien-Dindo Classification will be
monitored [11].
Inclusion criteria
– All patients that will present at the emergency
department with abdominal pain and a clinical
suspicion of acute appendicitis:
– Age >18 years of age
– Clinical suspicion of appendicitis as the primary or
differential diagnoses
– Patients able to provide informed consent
Exclusion criteria
– Age <18 years of
– Abdominal discomfort without tenderness or
rebound or clinical suspicion of appendicitis
– Pregnancy
– Patients with impaired consciousness
– Patients not able to provide informed consent
(Non-German Speakers)
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– Patients that will receive an appendectomy as
part of another elective procedure
– Patients who are unable to understand the
study purpose.
– Family members of study investigators or
employees of the participating centers
Participating surgeons and clinics
Doctors in the Emergency Room who have the first con-
tact with the patients are interns, junior and senior resi-
dents as well as chief residents and attending surgeons
of the Department of Surgery. Operating surgeons are
senior residents, chief residents, attending surgeons as
well as consultant surgeons. Participating centers are the
Division of Visceral and Transplantation Surgery of the
University Hospital Zurich as well as affiliated clinics in
Switzerland. Several European hospitals will be partici-
pating in this trial as well.
Data collection and statistics
The assessment for patient recruitment starts in the very
beginning as soon as the patient attends the emergency
room (ER), receives a consultation and a doctor’s assess-
ment of the patient’s condition [Additional file 2]. If
there is a clinical suspicion of appendicitis, the patient
should be assessed for eligibility (inclusion and exclusion
criteria) to participate in the PSP Appendicitis Trial
[Additional file 3]. If any patient is assessed for eligibility
of inclusion in this trial but was found to meet any
of the exclusion criteria, the reason and explanation
of the exclusion should be also documented in the Clin-
ical Trial Management System (CTMS) [https://www.
PSPtrail.com] [12].
Once a patient is assessed for eligibility and is found
to meet the inclusion criteria, the patient should imme-
diately enter the trial before any investigations have
ordered blood tests, imaging, etc. The consent forms
and patient information have to be provided to the pa-
tient. If the patient does not agree to participate in the
trial, this should be documented in the online CTMS. If
the patient agrees to participate in this trial, blood has to
be taken for Pancreatic Stone Protein (PSP) measure-
ment (1 tube of 5-10 ml, for serum determination in
clinical chemistry). This tube has to be labelled as B1
followed by the patient trial number (B1_II_YYYY). The
letter “B” stands for blood” and “1” as the first blood col-
lection. The patient trial number should be the name
initials (II) followed by the year of birth (YYYY). As
part of the standard care, blood has to be taken for
analysis for full blood count and CRP measurement at
participating institutions. In particular, the White
Blood Cell Count (WBC), Neutrophil Granulocytes (%)
and C-reactive Protein (CRP) will have to be entered
into the CTMS. The blood has to be taken at the same
time for PSP, WBC and CRP as soon as the patient
signs the consent form while still at the emergency
department. A pregnancy test (beta hCG) has to be
also performed and information entered into the
CTMS. The investigators are free to perform any
other blood tests deemed necessary.
The investigators are free to use any kind of imaging
as part of the routine management of patients. Ultra-
sound Scan (USS) or Computed Tomography (CT) data
will be entered in the CTMS.
The physician will then decide whether the patient
should be subject to further diagnostics, referred to an-
other inpatient or outpatient department or be dis-
charged home [Additional file 4]. If the patient is
admitted for an operation, this has also to be documen-
ted in the CTMS. If the physician decides to take blood
to assess the progress of the patient before an operation
or discharge, an additional tube for PSP measurement is
taken (see above). This tube has to be labelled as
(B2_II_YYYY, e.g. B2_DR1978, see example above, “2”
stands for second blood test for PSP). The same centri-
fugation process has to be performed to sample B2 as
for B1.
Then the investigators will be asked to indicate
the type of the operation and the intra-operative find-
ings, if the patient was operated. During hospitalisa-
tion, the physician should document any complication
according to the Clavien-Dindo Classification of surgi-
cal complications. For the patients that were operated,
the physician will need to document the date of dis-
charge. Once the histopathology report of the resected
specimen has been received, the diagnosis will be
entered in the CTMS. To ensure standardized report-
ing, all centers will adhere to the above classification
of appendicitis.
Continuous variables will be compared with the
Student t, Mann–Whitney U, one-way ANOVA, and
Kruskal-Wallis tests, where appropriate. Differences
among proportions derived from categorical data will be
compared using the Fischer’s Exact or the Pearson χ2
tests, where appropriate. All p values will be two-sided
and considered statistically significant if p ≤ 0.05. Sensitiv-
ity, specificity, accuracy, positive predictive value (PPV),
negative predictive value (NPV), positive likelihood ratio
(PLR), negative likelihood ratio (NLR), Yuden’s index (YI),
diagnostic odds ratio (OR), and the receiver operator
characteristic (ROC) curve will be calculated. Data will
be presented as mean (SD), median (i.q.r.) and Odds
Ratios (95% CI) where appropriate. Reproducibility of
PSP measurements will be performed by duplicating
the samples and the variability assessed by the Pear-
son’s Correlation Coefficient. Statistical analysis will be
performed using SPSS Statistics version 20 (SPSS: An
IBM Company, Chicago IL, 2011).
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Ethics
This study is conducted in accordance with the princi-
ples of the Declaration of Helsinki and ‘good clinical
practice’ guidelines. The independent medical ethics
committee of canton Zurich (Kantonale Ethikkommis-
sion Zürich, Switzerland) has approved the study
protocol.
Discussion
The surgeon’s aim is to correctly diagnose the appendi-
citis and therefore to minimize the negative appendec-
tomy rate without increasing the incidence of
perforation [13]. He has to evaluate a diverse group of
patients who present at the ED with abdominal pain and
has to consider different aetiologies [14]. The goal of a
diagnostic accuracy approaching 100% sensitivity and
specificity should be reached in a time-, cost-, and
consultation-efficient manner [4].
The overall mortality rate of 0.2-0.8% is attributable to
complications of the disease rather than to surgical
interventions [2]. The mortality rate in children ranges
from 0.1% to 1%; in patients older than 70 years, the rate
rises above 20%, primarily because of diagnostic and
therapeutic delay [4,6]. Since delayed diagnosis and
treatment accounts for much of the mortality and mor-
bidity associated with appendicitis, it is the goal of the
surgeon to make an accurate diagnosis as early as pos-
sible. False positive diagnosis leads to unnecessary opera-
tions which are estimated at 5-15%, while false negative
diagnosis may lead to a delay that increases the chances
for perforation, peritonitis and sepsis.
Keeping in mind, that appendectomy carries a compli-
cation rate of up to 15%, as well as associated costs and
the discomfort of hospitalization and surgery, a reliable
diagnostic tool such as blood test would be of utmost
advantage [5].
Conclusion
The PSP Appendix Trial is a prospective, multi-center,
cohort study to assess the value of PSP in the diagnostic
workup of acute appendicitis.
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